The target of MUC17 transmembrane mucin MUC17
2025-07-07
Transmembrane mucins are major components of the gastric mucosal barrier, comprising a family of high-molecular-weight glycoproteins that are expressed by specialized epithelial ce...
Granulocyte colony stimulating factor receptor CSF3R
2025-07-02
CSF3R is a granulocyte colony-stimulating factor receptor, also known as GCSF-R or CD114. It is essential for granulocyte maturation and plays a key role in the proliferation, diff...
The immunosuppressive enzyme CD39
2025-07-01
The ATP-adenosine pathway plays a key role in establishing an immunosuppressive tumor microenvironment (TME) by converting proinflammatory extracellular ATP into immunosuppressive ...
The therapeutic target of systemic lupus erythematosus BDCA2
2025-06-30
CD303, also known as BDCA2, DLEC, or CLEC4C, is a unique type II C-type lectin receptor (CLR) found on human plasmacytoid dendritic cells (pDCs). It assists TLR-7/9 in recognizing ...
Bone morphogenetic protein antagonist GREM1
2025-06-27
Dysregulation of bone morphogenetic protein (BMP) signaling frequently occurs in cancer and may lead to dysregulated cancer stem cell (CSC) differentiation and promote tumorigenesi...
The myogenesis inhibitory factor MSTN
2025-06-24
Growth/differentiation factor 8 (GDF8), also known as myostatin (MSTN), is a specific negative regulator of skeletal muscle (SM) growth. As a member of the TGF-β family, it may be ...
Lymphocyte activation targets CD6
2025-06-23
CD6 is a type I transmembrane glycoprotein that belongs to the highly conserved scavenger receptor cysteine-rich superfamily (SRCR-SF). It is expressed on all developing and mature...